ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.
Synonyms: A-T mutated; Ataxia telangiectasia mutated; EC:2.7.11.1; Serine-protein kinase ATM
Storage: 2-8C
Application: Western Blotting Analysis: A 1:10,000 dilution from a representatve lot detected ATM in HeLa, NIH/3T3, and L6 cell lysate.Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representatve lot detected ATM in human small intestine and human pancreas tissue sections. Immunofluorescence Analysis: A 1:100 dilution from a representatve lot detected ATM in human kidney tissue sections.Affinity Binding Assay: A representative lot of this antibody bound human recombinant ATM with a KD of 3.6 x 10-6 in an affinity binding assay.Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany